Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C017487 |
2-mercaptoacetate |
OPRM1 exon affects the susceptibility to 2-mercaptoacetate | affects response to substance | 10802031
|
C523979 |
3-(3-dimethylamino-1-ethyl-2-methylpropyl)phenol |
3-(3-dimethylamino-1-ethyl-2-methylpropyl)phenol binds to and results in increased activity of OPRM1 protein | affects binding|increases activity | 17656655
|
C523979 |
3-(3-dimethylamino-1-ethyl-2-methylpropyl)phenol |
3-(3-dimethylamino-1-ethyl-2-methylpropyl)phenol binds to OPRM1 protein | affects binding | 17656655
|
D020875 |
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- |
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein | affects binding | 11991257
|
D020875 |
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- |
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [OPRM1 protein affects the reaction [Potassium results in increased abundance of Catecholamines]] | affects reaction|decreases reaction|increases abundance | 12031848
|
D020875 |
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- |
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [OPRM1 protein affects the reaction [Potassium results in increased transport of Barium]] | affects reaction|decreases reaction|increases transport | 12031848
|
D020875 |
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- |
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [OPRM1 protein results in increased transport of Barium] | decreases reaction|increases transport | 12031848
|
D020875 |
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- |
omega-Conotoxin GVIA inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [OPRM1 protein results in increased transport of Barium]] | decreases reaction|increases transport | 12031848
|
D020875 |
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- |
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to and results in increased activity of OPRM1 protein | affects binding|increases activity | 10988119 16954126
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of OPRM1 mRNA | affects expression | 16483693
|
D003913 |
Dextroamphetamine |
Dextroamphetamine affects the expression of OPRM1 mRNA | affects expression | 12629526
|
D001464 |
Barium |
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [OPRM1 protein affects the reaction [Potassium results in increased transport of Barium]] | affects reaction|decreases reaction|increases transport | 12031848
|
D001464 |
Barium |
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [OPRM1 protein results in increased transport of Barium] | decreases reaction|increases transport | 12031848
|
D001464 |
Barium |
omega-Conotoxin GVIA inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [OPRM1 protein results in increased transport of Barium]] | decreases reaction|increases transport | 12031848
|
D001464 |
Barium |
OPRM1 protein affects the reaction [Potassium results in increased transport of Barium] | affects reaction|increases transport | 12031848
|
D001464 |
Barium |
OPRM1 protein affects the transport of Barium | affects transport | 12031848
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of OPRM1 mRNA | decreases expression | 19428949
|
D002047 |
Buprenorphine |
Buprenorphine binds to and results in increased activity of OPRM1 protein | affects binding|increases activity | 16010532
|
D002047 |
Buprenorphine |
Buprenorphine binds to and results in increased activity of OPRM1 protein | affects binding|increases activity | 15966752
|
D020001 |
1-Butanol |
[1-Butanol inhibits the reaction [PLD2 protein results in increased chemical synthesis of Phosphatidic Acids]] affects the reaction [PENK protein binds to and results in increased activity of OPRM1 protein] | affects binding|affects reaction|decreases reaction|increases activity|increases chemical synthesis | 14720217
|
D002395 |
Catecholamines |
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [OPRM1 protein affects the reaction [Potassium results in increased abundance of Catecholamines]] | affects reaction|decreases reaction|increases abundance | 12031848
|
D002395 |
Catecholamines |
OPRM1 protein affects the reaction [Potassium results in increased abundance of Catecholamines] | affects reaction|increases abundance | 12031848
|
C009862 |
connective tissue-activating peptide |
connective tissue-activating peptide binds to and results in decreased activity of OPRM1 protein | affects binding|decreases activity | 16954126
|
C014347 |
decitabine |
decitabine affects the methylation of OPRM1 promoter | affects methylation | 17452465
|
C014347 |
decitabine |
[decitabine affects the methylation of OPRM1 promoter] which affects the expression of OPRM1 mRNA | affects expression|affects methylation | 17452465
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of OPRM1 mRNA | increases expression | 18721800
|
D004399 |
Dynorphins |
Dynorphins analog binds to OPRM1 protein | affects binding | 11270320
|
C105293 |
endomorphin 1 |
endomorphin 1 binds to and results in increased activity of OPRM1 protein | affects binding|increases activity | 10988119
|
C105294 |
endomorphin 2 |
endomorphin 2 binds to and results in increased activity of OPRM1 protein | affects binding|increases activity | 10988119
|
D000431 |
Ethanol |
OPRM1 protein affects the susceptibility to Ethanol | affects response to substance | 17339526
|
D005038 |
Ethylnitrosourea |
Ethylnitrosourea results in increased mutagenesis of OPRM1 gene | increases mutagenesis | 16495775
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of OPRM1 mRNA | increases expression | 18977430
|
D009020 |
Morphine |
Morphine binds to and results in increased activity of OPRM1 protein | affects binding|increases activity | 17656655
|
D009020 |
Morphine |
[Zymosan co-treated with Morphine] results in increased expression of OPRM1 mRNA | affects cotreatment|increases expression | 15979727
|
C034643 |
naloxonazine |
naloxonazine binds to and results in decreased activity of OPRM1 protein | affects binding|decreases activity | 10802031
|
D009270 |
Naloxone |
Naloxone binds to and results in decreased activity of OPRM1 protein | affects binding|decreases activity | 10988119
|
D009271 |
Naltrexone |
Naltrexone binds to and results in decreased activity of OPRM1 protein | affects binding|decreases activity | 19657356
|
C025256 |
nonylphenol |
nonylphenol results in increased expression of OPRM1 mRNA | increases expression | 15620428
|
D020866 |
omega-Conotoxin GVIA |
omega-Conotoxin GVIA inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [OPRM1 protein results in increased transport of Barium]] | decreases reaction|increases transport | 12031848
|
D010712 |
Phosphatidic Acids |
[1-Butanol inhibits the reaction [PLD2 protein results in increased chemical synthesis of Phosphatidic Acids]] affects the reaction [PENK protein binds to and results in increased activity of OPRM1 protein] | affects binding|affects reaction|decreases reaction|increases activity|increases chemical synthesis | 14720217
|
D010852 |
Picrotoxin |
Picrotoxin results in increased expression of OPRM1 mRNA | increases expression | 15170462
|
D011188 |
Potassium |
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [OPRM1 protein affects the reaction [Potassium results in increased abundance of Catecholamines]] | affects reaction|decreases reaction|increases abundance | 12031848
|
D011188 |
Potassium |
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [OPRM1 protein affects the reaction [Potassium results in increased transport of Barium]] | affects reaction|decreases reaction|increases transport | 12031848
|
D011188 |
Potassium |
OPRM1 protein affects the reaction [Potassium results in increased abundance of Catecholamines] | affects reaction|increases abundance | 12031848
|
D011188 |
Potassium |
OPRM1 protein affects the reaction [Potassium results in increased transport of Barium] | affects reaction|increases transport | 12031848
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of OPRM1 mRNA | decreases expression | 19465110
|
C012589 |
trichostatin A |
trichostatin A affects the expression of OPRM1 mRNA | affects expression | 17452465
|
D014635 |
Valproic Acid |
Valproic Acid affects the expression of OPRM1 mRNA | affects expression | 17452465
|
D014801 |
Vitamin A |
Vitamin A affects the expression of OPRM1 mRNA | affects expression | 17289162
|
D014801 |
Vitamin A |
Vitamin A affects the expression of OPRM1 protein | affects expression | 17289162
|
D015054 |
Zymosan |
Zymosan results in increased expression of OPRM1 mRNA | increases expression | 18977430
|
D015054 |
Zymosan |
[Zymosan co-treated with Morphine] results in increased expression of OPRM1 mRNA | affects cotreatment|increases expression | 15979727
|
D015054 |
Zymosan |
Zymosan results in increased expression of OPRM1 mRNA | increases expression | 15979727
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
12.38 | 17676605 18926900 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
12.38 | 15322242 14514962 11752688 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
12.38 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
9.41 | 19490988 |
MESH:D000015 |
Abnormalities, Multiple |
|
Vitamin A |
9.41 | 10992263 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
9.38 | 18287403 |
MESH:D000138 |
Acidosis |
|
Ethanol |
9.38 | 11192467 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
3.73 | 11850527 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
1.90 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
6.32 | 6695378 |
MESH:D000236 |
Adenoma |
|
Ethylnitrosourea |
6.32 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.05 | 16835633 |
MESH:D000303 |
Adrenal Cortex Diseases |
|
Catecholamines |
6.99 | 6895166 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
4.99 | 15451040 15451039 |
MESH:D000437 |
Alcoholism |
|
Naltrexone |
5.80 | 18552399 18482155 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
4.90 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
13.40 | 11748828 |
MESH:D000740 |
Anemia |
|
Vitamin A |
13.40 | 16960172 |
MESH:D000740 |
Anemia |
|
Zymosan |
13.40 | 18664788 |
MESH:D018798 |
Anemia, Iron-Deficiency |
|
Vitamin A |
4.52 | 16960172 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
4.50 | 15513904 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
8.14 | 11141031 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
8.14 | 17497229 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.76 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
3.57 | 15238619 |
MESH:D001169 |
Arthritis, Experimental |
|
Zymosan |
3.92 | 16872482 15944321 15142272 17659584 15188379 |
MESH:D001249 |
Asthma |
|
Vitamin A |
3.25 | 16732791 |
MESH:D001259 |
Ataxia |
|
1-Butanol |
5.28 | 7820390 |
MESH:D001321 |
Autistic Disorder |
|
Naltrexone |
2.95 | 8570775 9028057 19393386 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.95 | 17507914 15238991 18316065 17688650 20603192 16609825 18396377 18775368 19232924 19460635 18177632 18940202 18985861 18558336 17157402 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
2.91 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.76 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.46 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.33 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.33 | 8888407 |
MESH:D001927 |
Brain Diseases |
|
Ethylnitrosourea |
4.60 | 14991843 |
MESH:D002545 |
Brain Ischemia |
|
Morphine |
4.82 | 19211983 |
MESH:D001932 |
Brain Neoplasms |
|
Ethylnitrosourea |
4.01 | 18412241 16436596 16357521 16651633 15144691 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.89 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
1.89 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
1.89 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.89 | 20435547 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Vitamin A |
5.27 | 17377406 17426644 |
MESH:D002056 |
Burns |
|
Ethanol |
4.33 | 16374292 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.55 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
2.36 | 15289165 18788625 15763234 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.34 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
4.34 | 19215824 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
6.24 | 19332462 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.24 | 16120746 18670907 18850075 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Ethylnitrosourea |
3.51 | 16003739 |
MESH:D016543 |
Central Nervous System Neoplasms |
|
Ethylnitrosourea |
5.65 | 17160924 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.59 | 20734317 |
MESH:D015362 |
Child Nutrition Disorders |
|
Vitamin A |
5.14 | 16153327 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.89 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Vitamin A |
4.06 | 16175620 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
3.41 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
9.16 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
9.16 | 15340226 16354765 8697196 12621046 15668235 |
MESH:D002972 |
Cleft Palate |
|
Vitamin A |
9.16 | 16054864 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
3.94 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
Vitamin A |
3.94 | 17219422 16267017 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.10 | 18981723 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.79 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
5.14 | 15513904 10194807 15451039 11873399 15451040 19302082 11198716 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
5.14 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
5.14 | 16575769 17688650 8888407 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin A |
5.14 | 10992263 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Vitamin A |
3.41 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.59 | 17107852 |
MESH:D003967 |
Diarrhea |
|
Morphine |
4.22 | 2540324 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
5.68 | 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
5.68 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
5.68 | 19641884 1733752 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.52 | 11462148 |
MESH:D015352 |
Dry Eye Syndromes |
|
Vitamin A |
5.48 | 16146918 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.22 | 18367378 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.75 | 1851702 |
MESH:C538011 |
Eales disease |
|
Vitamin A |
5.29 | 9068938 |
MESH:D004476 |
Ectodermal Dysplasia |
|
Ethylnitrosourea |
5.65 | 18357618 |
MESH:D004480 |
Ectromelia |
|
Vitamin A |
5.49 | 16054864 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.15 | 11000095 12711302 |
MESH:D004487 |
Edema |
|
Zymosan |
6.15 | 7907874 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.57 | 15322242 18230668 16714409 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
12.92 | 19294695 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
trichostatin A |
12.92 | 19294695 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.74 | 10568697 9294722 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.07 | 15821434 17637181 15328337 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
3.84 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.59 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.77 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Naloxone |
8.59 | 6254150 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
8.59 | 7562514 6426943 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
3.98 | 7750514 |
OMIM:600669 |
EPILEPSY, IDIOPATHIC GENERALIZED |
marker/mechanism |
|
| |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.74 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.30 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
4.30 | 16704527 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.77 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
11.57 | 19004024 18296743 19551842 17967931 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
11.57 | 16409862 19236843 18620774 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
11.57 | 14986274 19224547 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
5.33 | 17920746 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
4.97 | 15513904 10194807 15451040 16946407 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.14 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.56 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
3.82 | 8888407 18558336 |
MESH:D005327 |
Fetal Resorption |
|
Vitamin A |
5.03 | 16054864 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
3.73 | 9205823 11852909 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
7.57 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
7.57 | 20067830 |
MESH:D005756 |
Gastritis |
|
Ethanol |
4.36 | 15046732 |
MESH:D005909 |
Glioblastoma |
|
Ethylnitrosourea |
7.02 | 16436596 |
MESH:D005909 |
Glioblastoma |
|
trichostatin A |
7.02 | 18801729 |
MESH:D005910 |
Glioma |
|
Ethylnitrosourea |
3.36 | 18412241 16651633 16357521 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.26 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.27 | 19215824 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
10.22 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.22 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin A |
10.22 | 16080930 10992263 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.10 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.05 | 11000095 |
MESH:D006501 |
Hepatic Encephalopathy |
marker/mechanism |
|
| 11991257 |
MESH:D006505 |
Hepatitis |
|
Zymosan |
4.39 | 19110552 |
MESH:D006526 |
Hepatitis C |
marker/mechanism |
|
| 17299060 |
MESH:D006526 |
Hepatitis C |
|
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- |
5.86 | 17299060 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.58 | 15340226 12621046 16120746 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin A |
3.50 | 15707848 16863852 16490937 16877224 16292552 17436238 |
MESH:D006556 |
Heroin Dependence |
|
Buprenorphine |
6.76 | 12756210 |
MESH:D015658 |
HIV Infections |
|
Vitamin A |
3.65 | 16960176 |
MESH:D006679 |
HIV Seropositivity |
|
Vitamin A |
5.27 | 17209195 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.54 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.71 | 16354765 16959395 15340226 18606429 8697196 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
3.47 | 18783367 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.30 | 21332399 |
MESH:D006946 |
Hyperinsulinism |
|
Naltrexone |
5.96 | 16901484 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.32 | 21332399 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.78 | 18850075 18670907 |
MESH:D006986 |
Hypervitaminosis A |
|
Vitamin A |
5.84 | 16054864 |
MESH:D020514 |
Hypokalemic Periodic Paralysis |
|
Potassium |
5.53 | 19822448 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
2.99 | 17581917 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
10.60 | 20412841 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
10.60 | 12878042 17255318 17237260 17963957 9205823 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
10.60 | 12878042 12200463 |
MESH:D007249 |
Inflammation |
|
Zymosan |
10.60 | 8014878 11289658 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
2.89 | 11836018 18457598 |
MESH:D019586 |
Intracranial Hypertension |
|
Vitamin A |
5.49 | 15955940 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.33 | 17255318 |
MESH:D043183 |
Irritable Bowel Syndrome |
|
Zymosan |
5.51 | 17553498 |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
9.15 | 15513904 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.15 | 16580747 |
MESH:D007680 |
Kidney Neoplasms |
|
Ethylnitrosourea |
3.67 | 17379185 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
3.89 | 15451040 |
MESH:D007938 |
Leukemia |
|
decitabine |
2.91 | 19235587 18980019 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
3.71 | 17236224 18454857 19117987 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
5.87 | 19010910 19387464 17679729 18704418 18460780 18206229 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
trichostatin A |
5.87 | 18206229 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
5.87 | 17596541 16294345 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.13 | 18055864 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.37 | 15821434 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
7.92 | 17676605 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Vitamin A |
7.92 | 16054864 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
10.18 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
10.18 | 15289165 |
MESH:D008103 |
Liver Cirrhosis |
|
Vitamin A |
10.18 | 16256175 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
4.77 | 18295389 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
4.69 | 18166357 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
4.69 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.69 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin A |
4.69 | 16248980 |
MESH:D008107 |
Liver Diseases |
|
Vitamin A |
3.07 | 16175620 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
10.49 | 17347304 17207112 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Vitamin A |
10.49 | 16762690 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
3.91 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
3.91 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.48 | 12151625 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Vitamin A |
5.48 | 17113696 |
MESH:D008171 |
Lung Diseases |
|
Vitamin A |
3.88 | 16863852 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
3.93 | 17228818 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
3.69 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
3.23 | 18569708 20869020 17053015 18520028 20464547 20135361 6695378 18816296 20064080 |
MESH:D008175 |
Lung Neoplasms |
|
Ethylnitrosourea |
3.23 | 17703301 16271038 6695378 16019985 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.23 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
decitabine |
7.14 | 19470736 |
MESH:D008223 |
Lymphoma |
|
Ethylnitrosourea |
7.14 | 15790496 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Ethylnitrosourea |
4.73 | 15375218 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Ethylnitrosourea |
3.31 | 10838139 18041768 10767621 |
MESH:D008545 |
Melanoma |
|
decitabine |
3.53 | 17785578 16505122 |
MESH:D008545 |
Melanoma |
|
trichostatin A |
3.53 | 16505122 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
3.88 | 15451040 18411066 |
MESH:D008579 |
Meningioma |
|
Ethylnitrosourea |
5.65 | 17943659 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
2.96 | 18803445 18765137 |
MESH:D009041 |
Motion Sickness |
|
Dextroamphetamine |
5.19 | 1613127 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
2.94 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
11.03 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
trichostatin A |
11.03 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
Vitamin A |
11.03 | 16374440 |
MESH:D009102 |
Multiple Organ Failure |
|
Zymosan |
4.91 | 15241586 15213630 18160304 12879239 10479408 10890648 15259001 17724436 12130978 15834315 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.74 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
6.88 | 18608210 19157545 19010910 16882708 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
6.88 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.76 | 12213967 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
4.56 | 11141357 |
MESH:D009369 |
Neoplasms |
|
decitabine |
4.56 | 19470736 19116145 17925555 |
MESH:D009374 |
Neoplasms, Experimental |
|
Ethylnitrosourea |
4.09 | 16707424 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
2.91 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
6.97 | 16359493 8888407 |
MESH:D009436 |
Neural Tube Defects |
|
Vitamin A |
6.97 | 17400914 |
MESH:D009442 |
Neurilemmoma |
|
Ethylnitrosourea |
5.09 | 16003739 17160924 16651423 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
2.21 | 20132043 17217161 20518802 21332399 11836018 16723640 18674790 18457598 19632207 |
MESH:D009837 |
Oligodendroglioma |
|
Ethylnitrosourea |
5.65 | 17160924 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
4.91 | 19331143 19259094 |
MESH:D010051 |
Ovarian Neoplasms |
|
trichostatin A |
4.91 | 19331143 |
MESH:D010146 |
Pain |
|
3-(3-dimethylamino-1-ethyl-2-methylpropyl)phenol |
7.40 | 17656655 |
MESH:D010146 |
Pain |
|
Morphine |
7.40 | 16273134 15275824 15215642 18699797 6776300 20225289 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
8.11 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
8.11 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
trichostatin A |
8.11 | 19294695 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.92 | 12520081 |
MESH:D010538 |
Peritonitis |
|
Zymosan |
4.57 | 18557954 17826846 19088179 19641140 14761945 15259001 15979727 18977430 11985352 18760300 17371808 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.23 | 12224865 11605937 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.25 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.38 | 11399792 11118676 11222880 11896295 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
8.38 | 20603192 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
11.36 | 17616702 |
MESH:D055728 |
Primary Myelofibrosis |
|
trichostatin A |
11.36 | 17616702 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.58 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
trichostatin A |
3.58 | 18798265 19789329 |
MESH:D011537 |
Pruritus |
|
Naloxone |
10.01 | 15861022 |
MESH:D011537 |
Pruritus |
|
Naltrexone |
10.01 | 15861022 19657356 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.21 | 12752131 11422049 |
MESH:D015427 |
Reperfusion Injury |
|
Morphine |
3.97 | 19211983 |
MESH:D012127 |
Respiratory Distress Syndrome, Newborn |
|
Vitamin A |
5.48 | 16877224 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.52 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.53 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
9.98 | 19155313 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
9.98 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.03 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Ethanol |
8.82 | 9754883 |
MESH:D012640 |
Seizures |
|
Picrotoxin |
8.82 | 8635557 8954991 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
8.82 | 1511512 11738929 17978042 16876388 15475178 14763951 11044598 3137016 |
MESH:D018805 |
Sepsis |
|
Zymosan |
4.38 | 11441115 |
MESH:D012871 |
Skin Diseases |
|
Vitamin A |
3.27 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
4.95 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
4.95 | 16192470 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.53 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.21 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
3.25 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
3.25 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
3.25 | 18456281 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
3.25 | 9562338 16755016 17189318 17918041 9211565 11906479 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
3.97 | 9754883 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
3.88 | 15821434 |
MESH:D013953 |
Thymus Neoplasms |
|
Ethylnitrosourea |
4.83 | 15790496 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.57 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
3.09 | 17967635 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
4.90 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.19 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
4.69 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
4.69 | 17616700 19087683 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.32 | 8888407 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
4.58 | 17785578 |
MESH:D014605 |
Uveitis |
|
Zymosan |
5.07 | 11006244 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.26 | 12125929 |
MESH:D014802 |
Vitamin A Deficiency |
|
Vitamin A |
4.98 | 16175781 16146918 16960172 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.92 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.47 | 16723640 |